MDS
Iron Road

Guidelines for the diagnosis, workup and management of iron overload in MDS from the Canadian Consortium on MDS

Enter - English

The content of this program is supported by an unrestricted educational grant from Novartis Inc and Bristol Myers Squibb (BMS).

This tool is designed to help streamline the care of MDS patients with iron overload (IOL).

It features comprehensive information on clinical endpoints impacted by IOL reduction and the outcome of a Canada-wide physician consensus on best practices in IOL management in MDS. It will support physicians in their treatment of MDS patients with IOL.